Diet, nutrition and Parkinson’s: what you need to know
Recipes & Nutrition
Author: Caithlin NgPublished: 14 May 2020
Prep: Cook: Serves:
From the benefits of a Mediterranean diet to the best foods to take medication with, we share highlights from a recent webinar on ‘Nutrition – the emerging role of diet and Parkinson’s’
Diet and nutrition have been found to play a crucial role in Parkinson’s. In a recent ‘Ending Parkinson’s Disease: Live’ webinar, Parkinson’s expert Dr Bastiaan Bloem, epidemiologist Dr Alberto Ascherio and Parkinson’s campaigner Omotola Thomas, considered how different foods can affect the risk of diagnosis, maintaining bowel health and more.
We share five key takeaways from their discussion.
1. Which foods can affect your risk of developing Parkinson’s?
Diet, said Dr Bloem, “is a really hot topic in the field
of Parkinson’s”. Alongside exercise, diet and nutrition “are the big new kids
on the block when it comes to improving symptoms, and perhaps, slowing down the
progression of the disease.”
Dr Bloem and Dr Ascherio praised the Mediterranean diet, which varies by country and region, for its potential to lower the risk of developing Parkinson’s. The Mediterranean diet is generally high in vegetables, fruits, grains, healthy fats and fish, and is typically low in meat and dairy. Such a diet is rich in nutrients and antioxidants, making it “better than the traditional Western diet”, according to Dr Ascherio.
On the other hand, Dr Bloem theorised that “a lifetime of
exposure to dairy” is associated with a higher risk of developing Parkinson’s,
likely due to the pesticides ingested by cattle from contaminated grass.
Dr Ascherio added: “I don’t think that globally, dairy products are known to be a major cause of pesticide exposure. Dairy also has other effects like reducing the level of uric acid in blood, which we found to be related to a risk of Parkinson’s disease.”
2. Could you be malnourished if you have Parkinson’s?
While Dr Bloem pointed out that a regular diet should
offer all the necessary nutrients, he did note that vitamin D and vitamin C can
be exceptions. “Many people, particularly when you age and particularly when
you’re a woman, are at risk of developing a vitamin D deficiency. There are
fascinating anecdotal reports of people taking vitamin D and experiencing
improved motor symptoms.”
Meanwhile, he explained, vitamin C supplements can help to
prevent bladder infections in Parkinson’s patients by acidifying the urine. “Bladder
infections can trigger a cascade that leads to worsening Parkinson’s symptoms.”
Dr Bloem also debunked the use of supplements like vitamin E, curcumin and Coenzyme Q190, which have been found to offer no benefits to people with Parkinson’s.
3. How can you maintain your bowel health?
Bowel problems are common in Parkinson’s patients, which
Dr Bloem said can be alleviated by drinking a lot of water and eating a diet
rich in fibres. People with Parkinson’s should see their general practitioner
for laxatives only if all else fails. “The rule is you need to have bowel
movements at least once every other day.”
Thomas added: “I have a three litre water bottle that I finish by the end of the day. It is a challenge, but I try to finish it. Because I struggle very greatly with constipation, I take three or four ounces of prune juice in the morning and that seems to help me.”
4. How should you take your Parkinson’s medication?
As food can interfere with the efficacy of levodopa
medication, Dr Bloem recommended taking levodopa at least half an hour before
or after a meal. In particular, he advised that protein intake be spread across
“For most patients, taking your medication with a protein
rich meal including dairy products and meat, can reduce gastrointestinal absorption
of your levodopa. So, you need the proteins in order to keep up your muscle
strength and avoid weight loss but try to spread the proteins over the day.”
Thomas acknowledged that this can be hard to do. She said:
“I have a struggle spreading my proteins with my levodopa because I can’t take
more than 15mg of levodopa at a time, so I’m taking it every two hours.
“That is one of those things whereby theoretically, I know what I’m supposed to do, but practically, I’m not able to.”
5. Should a dietician be part of your standard Parkinson’s care?
Yes, said Dr Bloem. “I think paying attention to the gut
is part of routine clinical care at every consultation for people with
Parkinson’s. Parkinson’s starts in the gut for many patients and slow bowel
movements are very common, impacting the efficacy of your medication and
appetite for food. It needs attention.”
While a Parkinson’s doctor or nurse can offer useful
dietary advice, Dr Bloem himself recommends that his patients see a dietician
at least once. “I think it’s part of standard care.”
Watch the full webinar:
Need to know
Dr Bastiaan Bloem is a professor of neurology and director of the Parkinson’s Centre of Excellence at Radboud University Medical Centre, the Netherlands, and co-author of ‘Ending Parkinson’s Disease: A Prescription for Action’, in which experts outline a bold plan to “prevent, advocate, care and treat” Parkinson’s.
Dr Alberto Ascherio is a professor of epidemiology and nutrition at the Harvard T. H. Chan School of Public Health, US,
Omotola Thomas was diagnosed with young-onset Parkinson’s in 2016. She is a mother, blogger, Parkinson’s campaigner and founder of ParkinStand – a platform designed to encourage people to fight Parkinson’s through physical and mental activities.
For more information about Parkinson’s and healthy eating, please visit the EPDA website.
Watch: Icelandic football team takes to the pitch in Parkinson’s tops
Parkinson’s took centre stage in an international friendly against Ghana
3 days ago
Diesel exhaust fumes may increase the risk of Parkinson’s, study suggests
A new study by researchers in the US has found evidence that chemicals in diesel exhaust fumes can damage brain cells – and potentially increase the risk of Parkinson’s. As part of the study – published in ‘Toxicological Sciences’ – researchers tested the effects of diesel exhaust fumes on zebrafish, as their neurons interact in a similar way to those of humans. The researchers found that after being exposed to the chemicals, the zebrafish had fewer cells that dispose of toxic build-up of the protein alpha-synuclein, which occurs in Parkinson’s. The researchers replicated the experiment with cultured human cells and found similar results. Dr Jeff Bronstein, a professor of neurology at the University of California, Los Angeles (UCLA), US, said: “Overall, this report shows a plausible mechanism of why air pollution may increase the risk of Parkinson’s disease.”
Can Covid-19 increase the risk of developing Parkinson’s?
Parkinson’s could be caused or modulated by infections like Covid-19, a new study suggests – though more evidence is needed to draw a definitive conclusion. As part of the study, researchers from the Federal University of São Paulo, Brazil, drew on previous findings to support their hypothesis. For example, studies in mice have found that infection with some strains of influenza could cause neural changes similar to those in Parkinson’s. Furthermore, people born during or around the 1918 influenza pandemic were over twice as likely to develop Parkinson’s than those born in the decades before or after. Patrik Brundin, co-editor-in-chief of the Journal of Parkinson’s Disease, said that while it’s “too early to know what the long-term consequences of Covid-19 will be on the brain, the clinical psychiatry and neurology research communities definitely need to be vigilant in monitoring how those who recover from moderate and severe Covid-19 fare in…
New Parkinson’s trial platform could “dramatically speed up the search for a cure”
Scientists have proposed the use of a multi-arm, multi-stage trial platform (MAMS) to assess different potential treatments for Parkinson’s and help progress the search for a cure. This would depart from conventional clinical procedures, allowing several potential treatments to be assessed simultaneously. In a continuous process, each treatment ‘arm’ is evaluated and unsuccessful ‘arms’ of the trial are dropped, enabling a far more cost and time efficient system. Currently, MAMS are used to evaluate treatments for certain types of cancer – and work is underway to develop MAMS for other neurodegenerative conditions. Camille Buchholz Carroll, associate professor at the University of Plymouth, UK, and study author, said that MAMS trials could “dramatically speed up the search for a cure”. She said: “We have the opportunity to learn from the experience in these other conditions and design a new trial that will work for people with Parkinson’s.”